DS
NVAX icon

DRW Securities’s Novavax NVAX Stock Holding History

DRW Securities’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-11,200
Closed -$2.03M – 338
2021
Q1 		$2.03M Buy
+11,200
New +$2.23M 0.08% 52

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DRW Securities's NVAX Position: Q1 2026 in Review

DRW Securities increased its Novavax (NVAX) stake by 98% in Q1 2026, buying an estimated $106K and bringing the position to 23,607 shares worth $192K. The position accounts for ﹤0.01% of the portfolio, ranked #1129.

DRW Securities first reported a position in NVAX in Q1 2021 and has held it in 4 quarters since. The position peaked at $1.01M in Q1 2021. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • DRW Securities held 23,607 shares of Novavax worth $192K as of Q1 2026.
  • DRW Securities bought 11,707 Novavax shares in Q1 2026, an estimated $106K.
  • Novavax made up ﹤0.01% of DRW Securities's portfolio in Q1 2026, its #1129 holding.
  • DRW Securities first reported a position in Novavax in Q1 2021 and has held it in 4 quarters since.
  • DRW Securities's Novavax position peaked at $1.01M in Q1 2021.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.